about
Clinical follow-up predictors of disease pattern change in anti-Jo1 positive anti-synthetase syndrome: Results from a multicenter, international and retrospective study.Serum Jo-1 Autoantibody and Isolated Arthritis in the Antisynthetase Syndrome: Review of the Literature and Report of the Experience of AENEAS Collaborative Group.First Real-World Insights into Belimumab Use and Outcomes in Routine Clinical Care of Systemic Lupus Erythematosus in Germany: Results from the OBSErve Germany Study.Cardiovascular Comorbidity in Inflammatory Rheumatological Conditions.Increased expression of costimulatory markers CD134 and CD80 on interleukin-17 producing T cells in patients with systemic lupus erythematosus.Self-assessments of patients via Tablet PC in routine patient care: comparison with standardised paper questionnaires.Rheumatoid arthritis: autoreactive T cells recognising a novel 68k autoantigenClinical Spectrum Time Course in Anti Jo-1 Positive Antisynthetase Syndrome: Results From an International Retrospective Multicenter Study.Gene-expression analysis of adult-onset Still's disease and systemic juvenile idiopathic arthritis is consistent with a continuum of a single disease entity.Molecular imaging of cartilage damage of finger joints in early rheumatoid arthritis with delayed gadolinium-enhanced magnetic resonance imaging.Arthroscopic synovectomy and radiosynoviorthesis: a treatment option for recurrent arthritis symptoms in patients with pachydermoperiostosis.Hereditary periodic fever with systemic amyloidosis: is hyper-IgD syndrome really a benign disease?[Germany's largest healthcare study NAKO with musculoskeletal examination program has started].RheumaNet--a novel Internet-based rheumatology information network in Germany.Novel 68 kDa autoantigen detected by rheumatoid arthritis specific antibodies.Differential diagnosis of high serum creatine kinase levels in systemic lupus erythematosus.Polymorphisms of the xenobiotic-metabolizing enzymes CYP1A1 and NAT-2 in systemic sclerosis and lupus erythematosus.Health care and burden of illness in systemic lupus erythematosus compared to rheumatoid arthritis: results from the National Database of the German Collaborative Arthritis Centres.[Anti-interferon alpha therapy of systemic lupus erythematosus].Utility of combined high-resolution bone SPECT and MRI for the identification of rheumatoid arthritis patients with high-risk for erosive progression.Acquired factor VIII inhibitors in nonhemophilic patients.Analysis of fertility data in A.I. populations.Pregnancy outcome in patients with antiphospholipid syndrome after cerebral ischaemic events: an observational study.Pregnancy in systemic lupus erythematosus and antiphospholipid syndrome.Changing attitudes towards online electronic health records and online patient documentation in rheumatology outpatients.Peripheral circulating activated b-cell populations are associated with nephritis and disease activity in patients with systemic lupus erythematosus.Maternal Thrombophilia and Recurrent Miscarriage - Is There Evidence That Heparin is Indicated as Prophylaxis against Recurrence?[Rheumatology - Integration into student training (RISA) : Current structure of clinical rheumatology in German universities (RISA III)].[An example of internet-based quality assurance in rheumatology].Effects of glucocorticoids in rheumatoid arthritis. Diminished glucocorticoid receptors do not result in glucocorticoid resistance.Genes responding to Canakinumab therapy in SJIA are -inversely - disregulated in adult onset Still's disease.[S2e guideline: treatment of rheumatoid arthritis with disease-modifying drugs]Swimming against the stream: the fishbowl discussion method as an interactive tool for medical conferences: experiences from the 11th European Lupus MeetingImmunoglobulin allotypes are not associated with HLA-antigens, autoantibodies and clinical symptoms in systemic lupus erythematosus. Members of the SLE Study GroupHetero- and homozygosity of MHC class II gene products in systemic lupus erythematosus. The Members of the Deutsche Multizentrische SLE-StudieImmunoglobulin allotypes in systemic lupus erythematosus--results of a central European multicenter study. SLE Study Group[Significant association of HLA-B8 with systemic lupus erythematosus and with specific serological markers][Association of HLA-antigens with systemic lupus erythematodes and its symptoms (author's transl)]Hyperprolactinemia in systemic lupus erythematosus?Antiphospholipid syndrome complicating chronic graft-versus-host disease after allogeneic bone marrow transplantation
P50
Q30238667-538E27DE-EB67-41D7-AB1D-A7B37058193CQ30251952-4EE828DF-C4CD-49C1-BD64-3C10DE7286F3Q30490276-E9F7A4E1-2457-4A2C-A748-2E2819C1D20AQ33582869-8CD771B9-24ED-4094-9472-BF079A2B9CBCQ34153057-D4BBFB77-57B5-40E8-BAE2-6FBF4A8E1484Q34799376-65A793E9-570D-4CCF-AE80-B53E4E55679EQ35547245-6D187D90-BE45-49E3-BA20-95BC9643662FQ36195131-EDD80C26-27EF-4A38-A8B6-F69A3343E4BAQ36304070-5F2F6650-45ED-4FA7-8322-9B94EF9245FAQ37939610-E99FB96A-B0C8-43F2-90A3-02316556CF70Q38123367-95EC4443-123E-4BD8-A787-CF713CFC7277Q40471559-B761B60B-32FB-4DD1-A907-6175A4545CE8Q40696340-39FE0A6C-1DEE-4180-93EB-633608BF403BQ40838829-B79E84A1-C1FF-4568-98EE-939AD74659BDQ41286184-B323FE6F-B13F-4BC1-93BE-1F08E68E7AF8Q41915922-7AE16EC6-CF60-4177-8765-32D724D7823CQ42481147-4F01A97D-046D-4123-BDF2-C3C8E09EBDAFQ44089331-2223B4C4-1B22-490E-9FC1-EA97AE72D9D9Q44510622-B629F7E6-8149-4C9D-B2D0-B60789D7E9EEQ45398800-C9CFF6C2-2322-49D6-B830-568FA253D2E1Q45880974-343A362A-1417-4CF5-A7EA-371818F484B9Q45968577-F822078A-9D38-42A6-AD34-A550D474AC20Q48477588-468E7260-14C1-4868-AC0B-204E6CD09EE7Q49966447-F884651C-7FD4-4FA9-8FFC-371D4DB68FADQ50139261-9F8371C2-3221-43C0-8678-4CCE2493026CQ51737611-313A7317-0413-4B2D-95E1-A5B4C0EA20B3Q52806708-4A065144-E64F-404C-850C-3CD1CAABBBF2Q52852176-88D06A41-E466-4C90-BF2E-09CFAB465D1CQ53854372-A3543A4D-C091-4196-9C68-B35F9376CE57Q54198052-43556438-B118-4CD6-9530-3CCE4C5ED16AQ55000662-4C4BF87A-965C-4F68-9564-5F24FA04990CQ56968449-937CC40C-EF8B-4A0D-A8DE-2E904D765F6EQ58615315-B4AACB20-2A21-43CA-8CF2-2A01C489348DQ67844662-B79F9542-2657-443F-A091-D3F12CA4BA2BQ67873720-664EAC18-7D28-4582-B0BB-C98A113A6EABQ67999421-DF5CB156-A357-4A96-AC6C-A94EB3F43247Q68816848-88298711-358D-4FB9-AA97-F9BAB106FA69Q70336054-1632C471-DC3C-418F-98BB-CF175D66FDDFQ71042380-B3929698-F32A-411D-9A70-6D1798F96685Q72204435-D82334A3-4FA3-47AC-BA67-4470BE2FB3DB
P50
description
Forscher
@de
chercheur
@fr
investigador
@es
researcher
@en
ricercatore
@it
wetenschapper
@nl
研究者
@zh
name
C Specker
@ast
C Specker
@en
C Specker
@es
C Specker
@nl
type
label
C Specker
@ast
C Specker
@en
C Specker
@es
C Specker
@nl
prefLabel
C Specker
@ast
C Specker
@en
C Specker
@es
C Specker
@nl
P31
P496
0000-0003-2504-3229